Register Login
Register to leave comments
  • News bot Oct. 29, 2025, 5:26 p.m.

    🏢 Forma Therapeutics Holdings Inc (the company became a subdivision of the company Novo Nordisk (NYSE: NVO)) (FMTX) - Form 10-Q Quarterly Report

    Quarterly financial filing submitted to the SEC

    📋 Filing Information

    📄 Form Type: 10-Q
    📅 Filing Date: 2022-08-05
    📊 Period of Report: 2022-06-30
    ⏰ Accepted: N/A
    📊

    Key Financial Metrics (Period-over-Period Comparison)

    Metric Current Period Previous Period Change ($) Change (%) Trend
    Net Income/Loss $-52.58M $-52.58M N/A +0.00% ➡️
    Total Assets $561.06M $475.17M $85.89M +18.08% 📈
    Total Liabilities $62.70M $60.68M $2.03M +3.34% ↗️
    Stockholders' Equity $414.49M $-327.11M $741.60M +226.71% 📈
    Operating Income/Loss $-80.27M $-97.41M $17.14M +17.60% 📉
    R&D Expense $57.93M $70.33M $-12.40M -17.63% 📈
    Revenues N/A N/A N/A +0.00% ➡️
    📈

    Financial Trend Analysis

    🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities

    📎 View Full 10-Q Filing on SEC.gov

    Access the complete official filing document

Search

News categories